Skip to content

RYTM RHYTHM PHARMACEUTICALS INC

Follow

COM (common), issuer CIK 1649904

203 managers (205 13F filers) reported a position in RYTM shares at 2024-12-31, 64,917,510 shares in all. 38 filers opened a position and 24 filers sold out during the quarter.

Managers
203
13F filers
205
New
38
Added
66
Reduced
53
Sold out
24
Shares held by filers
64,917,510

Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.

13D and 13G filers

Each filer's latest stake. The shares are the aggregate the reporting persons state, which can include entities that file no 13F.

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q4 2024

Filers in the available 13F reports with a share position at 2024-12-31, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
AlphaQuest LLC1$56<0.01%-9,16613F-HRTimeline
CONCOURSE FINANCIAL GROUP SECURITIES, I…0$00%013F-HRTimelineValue filed as zero, left out of ratios. Amount filed as zero, left out of ratios.
NOMURA ASSET MANAGEMENT CO LTDin group NOMURA ASSET MANAGEMENT CO LTD0$00%013F-HRTimelineGroupValue filed as zero, left out of ratios. Amount filed as zero, left out of ratios.

Events

  • JPMORGAN CHASE & CO reported 3,563,667 RYTM shares, 5.1% of the class, as of 2026-09-30, in a 13G filed 2026-10-13. 0000019617-26-000351

    Accepted , ingested